301089.SZ
Tuoxin Pharmaceutical Group Co., Ltd.
SZSE · C 制造业 · CN
CNY 23.14
−4.38%Margins
Gross margin
24.8%
EBITDA margin
-1.5%
EBIT margin
-21.8%
Net margin
-20.5%
FCF margin
-10.8%
-5.2%
Return on equity
-4.6%
Return on assets
-5.5%
Return on invested capital
0.23x
Asset turnover
CNY 414.1K
Cash from operations
—
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026